Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy)
Clinical trial NCT05593614 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05593614
- Sponsor
- AlgoTherapeutix
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2024-09-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.